The European Commission on Wednesday proposed giving itself new powers to request scientific studies on the safety of products in an effort to quell public concerns that industry has too much influence over the process.
Should the plan be signed off by national capitals as well as the European Parliament, it would hand Brussels far-reaching capabilities to re-evaluate scientific studies submitted by companies in order to approve the likes of food additives, pesticide products and genetically modified food.
The Commissions proposal comes after lawmakers and campaigners complained vociferously last year that studies used to assess the carcinogenicity of the weedkiller glyphosate were kept secret. They accused Monsanto — the worlds biggest manufacturer of the substance — of ghostwriting some of the research, a claim that the U.S. concern has strongly denied.
“It goes without saying that the responsibility to demonstrate that a product is safe continues to lie with the industry,” European Commission Vice President Frans Timmermans told reporters as he unveiled the legislation in Brussels. “But in controversial cases EFSA [the European Food Safety Authority] will now also be able to commission its own studies financed from the EU budget.”
The new rules, if adopted by EU member countries, will affect all companies — including big players such as Germanys Bayer and the Swiss-based conglomerate Syngenta — looking to approve a wide range of products, including genetically modified food, food and feed additives, food enzymes and pesticides. As part of the new regime, the Commission would order the European Food Safety Authority to commission its own scientific studies should “exceptional circumstances” arise.
The new proposal, which emerged as part of a revision to the EUs General Food Law, did not specify what would count as an exceptional circumstance.
It would also oblige companies to post data from the studies they commission on EFSAs website so that scientists can assess the research independently.
But the Commissions move did not go far enough for some campaigners, who argued companies should play no role whatsoever in commissioning the studies that go into proving the safety of their products.
“The publication of test results supporting applications for pesticide approvals is the bare minimum. But the Commission is just papering over the cracks,” said Mark Breddy, a spokesperson for Greenpeace in Brussels. “Pesticide producers should not be allowed to control the testing of their own products. As a rule, this should be the job of the EU.”
The Commissions plan would give Brussels new powers to ensure that laboratories that conduct scientific studies comply with international standards. In recent years, public skepticism surrounding the independence of the science behind chemical substances — particularly pesticides and genetically modified food — has put pressure on EU countries not to approve such products for the marketplace even if the science concludes they are safe.
That has left the Commission in a tricky position when trying to decide whether to approve genetically modified crops for cultivation and risk taking the flak from the public. In November, the EU only just managed to gain enough support to renew the license of glyphosate, the worlds most common herbicide, thanks to a dramatic U-turn from Berlin, whose environment minister at the time, Barbara Hendricks, angrily asserted that she had been double-crossed by the conservative then-Agriculture Minister Christian Schmidt.
Timmermans defended the Commissions decision to keep industry involved in carrying out research to determine the safety of their products.
“Many of these studies are completely uncontroversial. If you can leave the financial burden on the ones who are going to profit from it and not put it on the shoulders of the taxpayers then that is good,” he said. “But if there is a controversy … then EFSA can intervene.”
The Commissions move follows an announcement last month from dozens of agrichemical companies pledging to release undisclosed documents containing safety data on their pesticides. Critics of the move, however, said they were skeptical about the transparency pledge because companies would still be able to hold back key data, citing corporate secrecy.
That option is also possible under the new Commission proposal, although companies will “have to provide verifiable justification for their possible confidentiality claims,” the EU executive said in a memo.
“I hope that the global commitment to further transparency from our industry, and the principles enshrined in this new proposal, will be met with a similar commitment by those on the other side of the debate who produce studies arguing against the need for, or approval of, pesticides,” said Graeme Taylor, director of public affairs at the European Crop Protection Association, an EU pesticide lobby.
Burkina Faso: Growing Violence Threatens Health Care
Away from the worlds attention, Burkina Faso has been slipping into violence. In less than a year, t..
Away from the worlds attention, Burkina Faso has been slipping into violence. In less than a year, the number of displaced has increased fivefold, from 50,000 last December, to 270,000 in August. As ever, the most vulnerable suffer most: the very young, and the very old.
When Alidou Sawadogos elderly mother fell ill, he faced a long and dangerous journey to get treatment for her.
“When she collapsed, a friend called me,” he explains. “By the time I arrived she was already unconscious. I decided to take her to the health center and luckily someone who had a motorcycle helped me. Because of the violence many people who are sick wait at home and die. Everyone is afraid of taking the road to the health center in Barsalogho.”
Across Burkina Faso, the rising insecurity has forced over a hundred health centers to close, or to limit their work. Half a million people now have little or no access to health care. Dedicated health workers, among them Dr Bertrand Dibli in Barsalogho, are struggling to meet the needs, and to stay safe themselves.
“This is one of the few health centers that isnt closed,” he says. “We dont have enough equipment. And the insecurity has caused huge anxiety among health workers. Even coming here to Barsalogho is a huge challenge because the route is so dangerous.”
The ICRC has been working to support Burkina Fasos health professionals, with medical kits, and vaccination campaigns. During his visit to the country, ICRC President Peter Maurer expressed his concern at the multiple challenges facing Burkina Fasos people.
“We are very concerned,” he said. “Very worried about the upsurge in violence, its a vicious circle that is trapping the civilian population between armed groups.”
“We also see,” Mr Maurer added, “that it is not only the violence that is affecting the country, it is also under development, and climate change. Together with the violence that is obstructing the health services, its an accumulation of factors.”
And so the ICRC – jointly with the Burkinabé Red Cross – is also delivering food to the displaced, and helping to improve access to water supplies. All of this, says nurse Jeanette Kientega, is desperately needed by a population uprooted by conflict, and denied access to basic health care.
“By the time they are able to get here, it is often too late” she says. “Sometimes we can help, but if they have already been ill a long time, it is difficult. We try to do what we can.” (more…)
World Bank and WHO Statement on Partnership & Deployment of Financing to WHO for Ebola Response in DRC
WASHINGTON, August 23, 2019—The World Bank and the World Health Organization (WHO), along with the G..
WASHINGTON, August 23, 2019—The World Bank and the World Health Organization (WHO), along with the Government and other key partners, are working in close partnership on the Ebola Crisis Response in the Democratic Republic of the Congo (DRC). Central to this partnership is the assessment of the financing needs, and deployment of resources, with the goal to put an end to the current deadly outbreak.
The World Bank is today announcing that US$50 million in funding is to be released to WHO for its lifesaving operational work on the frontlines of the outbreak. The WHO is announcing that this US$50 million in funds will close the financing gap for its emergency health response in DRC through to the end of September 2019, and is calling on other partners to mirror this generous support in order to fund the response through to December.
The funding comprises US$30 million from the Pandemic Emergency Financing Facility (PEF) and US$20 million from the World Bank. The US$50 million in grant funding is part of the larger financial package of approximately US$300 million that the World Bank announced last month to support the fourth Strategic Response Plan for the DRC Ebola outbreak.
“WHO is very grateful for the World Banks support, which fills a critical gap in our immediate needs for Ebola response efforts in DRC, and will enable the heroic workers on the frontlines of this fight to continue their lifesaving work,” said Dr. Tedros Adhanom Ghebreyesus, Director-General, World Health Organization. “We keenly await further funding from other partners to sustain the response through to the end of the year.”
The DRC government, working in collaboration with the World Bank, WHO, and other key partners, has finalized the Fourth Strategic Response Plan (SRP4), which outlines the total resources needed for the DRC Ebola Crisis Response from July to December 2019. The financing announced today is part of the World Banks previously announced financial package of up to US$300 million and covers over half of SRP4s needs, with the remainder requiring additional funding from other donors and partners.
“The World Bank is working closely with WHO, the Government of DRC, and all partners to do everything we can to put an end to the latest Ebola outbreak,” said Annette Dixon, Vice President, Human Development at the World Bank. “The partnership between our organizations and the Government is critical for responding to the emergency as well as rebuilding systems for delivery of basic services and to restoring the trust of communities.”
The Government of DRC requested US$30 million from the PEF Cash Window to be paid directly to WHO. The PEF Steering Body approved the request bringing the PEFs total contribution to fighting Ebola in DRC to US$61.4 million. The PEF is a financing mechanism housed at the World Bank; its Steering Body is co-chaired by the World Bank and WHO, and comprises donor country members from Japan, Germany and Australia. The quick and flexible financing it provides saves lives, by enabling governments and international responders to concentrate on fighting Ebola—not fundraising.
Borno State launches first Malaria Operational Plan, reawakens fight against malaria
Maiduguri, 13 August 2019 – Following recommendations from malaria interventions in Borno State Nige..
Maiduguri, 13 August 2019 – Following recommendations from malaria interventions in Borno State Nigeria, the Malaria Annual Operational Plan (MAOP) was developed and launched on 08 August 2019 with technical support from the World Health Organization (WHO) and partners. Aligned to the National Malaria Strategic Plan (2014 -2020), MAOP was developed through a broad-based stakeholders workshop involving malaria stakeholders, reviewed on different thematic areas and endorsed by the Commissioner for Health and Permanent Secretary, Borno State Ministry of Health.
Speaking during the launch, the Borno state Malaria Programme Manager, Mr Mala Waziri described the MAOP as the first to be endorsed and disseminated in Borno State. “WHO has made us proud by supporting the first ever Malaria Operational Plan right from development, review, printing to dissemination.”
Dr Ibrahim Kida, the Ministerial Secretary Borno State Ministry of Health and Incident Manager of the state, described the launch as “an historic event as stakeholders across the health sector made commitments to use the document as an implementation guide for all malaria programs”. The plan was also described as an advocacy tool for planning domestic funds mobilization.
The MAOP has seven objectives among which are: provide at least 50% of targeted population with appropriate preventive measures by 2020; ensure that all persons with suspected malaria who seek care are tested with Rapid Diagnostic Test (RDT) or microscopy by 2020 and all persons with confirmed malaria seen in private or public health facilities receive prompt treatment with an effective anti-malarial drug by 2020.
The MAOP will further ensure that at least 50% of the population practice appropriate malaria prevention and management by 2020, ensuring timely availability of appropriate anti-malarial medicines and commodities required for prevention, diagnosis and treatment of malaria in Borno State by 2020.
In addition, it seeks to ensure that all health facilities report on key malaria indicators routinely by 2020 and finally strengthen governance and coordination of all stakeholders for effective program implementation towards an A rating by 2020 on a standardized scorecard. These strategic objectives have specific targets and the MAOP takes into account the humanitarian response.
“Malaria remains a leading cause of poor health in Nigeria. According to the 2018 WHO Malaria Report, 53million cases are recorded annually in Nigeria, roughly 1 in 4 persons is infected with malaria contributing 25% of the global burden,” says Dr Nglass Ini Abasi, WHO Malaria Consultant for the North East.
“Furthermore, 81,640 deaths are recorded annually (9 deaths every hour), which accounts for 19% of global malaria deaths (1 in 5 global malaria deaths) and 45% malaria deaths in West Africa. The Nigeria Malaria Strategic Plan (NMSP) 2014-2020 has a goal to reduce malaria burden to pre-elimination levels and bring malaria-related mortality to zero and WHO is working assiduously with Government to ensure the burden is reduced accordingly.”
Results from WHO’s Early Warning, Alert and Response System (EWARS) week 30 report from 223 sites, (including 32 IDP camps) show that malaria was the leading cause of morbidity and mortality accounting for 35% of cases and 46% of reported deaths. In addition, results from the Nigeria Humanitarian Response Strategy (NHRS 2019-2021) indicate 7.1million people are in dire need of healthcare and 6.2million are targeted for immediate attention.
Despite recent improvements, insecurity remains a challenge limiting access to the functional health facilities. Easily preventable and treatable diseases such as malaria, acute respiratory infection and diarrheal diseases account for the greatest proportion of morbidity and mortality among the vulnerable population. Furthermore, Malaria is endemic in North East Nigeria and the transmission is perennial with a marked seasonal peak from July to November every year. (more…)
Australia3 years ago
Button and Diane Powellpark the school bus after three decades
Australia3 years ago
60th Annual Louth Cup 2018 | Photos
Australia3 years ago
A good attendance for planning ahead
Australia3 years ago
Severe, unusual weather likely to cause damage
Australia3 years ago
Ten ways to scrap plastic without breaking the bank
World3 years ago
Know-how: Canadian hospital first to сure patients with virtual reality
World3 years ago
Сhinese navy jets master daring night maneuvers on aircraft carrier (VIDEO)
fun4 years ago
Will Gompertz reviews Lin-Manuel Miranda’s musical Hamilton ★★★★★